Search results for '**' (3549 products)

Showing 1-10 of 3549

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on advanced therapeutics development for neurological disorders, oncology, immunological diseases. Peptide-drug conjugates, targeted antibodies, gene therapy, and cell therapies have also been discussed in this edition. Protein bioprinting, fiber-based c...

USD 950.00
13 Sep 2021  |  North America

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of ph...

USD 4,950.00
09 Sep 2021  |  North America

Global Medical Device Leasing Growth Opportunities

Vendors' Integration of Support Services and Shift from Product-centric to Value-oriented Business Models will Improve ROI and Margins for Healthcare Providers

Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...

USD 2,450.00
03 Sep 2021  |  North America

Global Renal Care Management Growth Opportunities

Value-based Renal Care to be a Key Growth Area

The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...

USD 4,950.00
31 Aug 2021  |  Global

Research Efforts Fuel the Future of Global Obstructive Lung Disease Management

Technology Developments Driving Transformational Growth in Treatment Modalities for Obstructive Lung Diseases

Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

USD 4,950.00
27 Aug 2021  |  North America

US and EU Upstream Bioprocessing Growth Opportunities

Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

USD 4,950.00

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations include a non-invasive glucose monitoring device, an implant for anterior cruciate ligament regeneration, a brain visualization neurosurgical tool, and a ultraviolet-C l...

USD 950.00
24 Aug 2021  |  North America

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

USD 2,450.00

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on development therapeutics for neurological disorders, mainly on drugs that target protein aggregates. A non-invasive brain computer interface (BCI) technology has also been discussed. Immunotherapeutics for cancer and other therapeutic indications have...

USD 950.00
03 Aug 2021  |  North America

Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021

A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines

During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...

USD 4,950.00

Showing 1-10 of 3549